Nonpenetrating very deep sclerectomy with hyaluronic acid implant vs trabeculectomy--a 2-year follow-up.

Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie
Rafał LeszczyńskiKrzysztof Pawlicki

Abstract

To study and compare the efficacy and safety of nonpenetrating very deep sclerectomy (NPVDS) with the use of hyaluronic acid implant (SKGEL) to trabeculectomy (TB) in patients with with medically uncontrolled glaucoma. Prospective, controlled study of patients with open-angle glaucoma was designed. Seventy-eight eyes of 68 patients with medically uncontrolled glaucoma were assigned either to the NPVDS or to the TB group of trial. Examinations were applied before and 7 days, 1, 3, 6, 12, 18, and 24 months after surgery. Best-corrected logMAR visual acuity, intraocular pressure, number of additional procedures, antiglaucoma medications, number of complications. At 24 months, success rate defined as IOP ≤ 21 mmHg with medication and additional procedures in NPVDS group was 92.31 %, and 94.88 % in control group (p = 0.64). There was no statistically significant difference between intraocular pressure in NPVDS (14.56 ± 4.07 mmHg ) and control (TB) (15.38 ± 3.38 mmHg) group (p = 0.34). Number of glaucoma mediations decreased from 2.18 ± 0.56 to 0.54 ± 0.56 in NPVDS and from 2.28 ± 1.41 to 0.61 ± 0.03 in TB group (p = 0.71). Early and late postoperative complications included two cases of hyphema, two of choroidal detachment, two of f...Continue Reading

References

Oct 1, 1968·American Journal of Ophthalmology·J E Cairns
Feb 1, 1968·The British Journal of Ophthalmology·M M Krasnov
Jun 1, 1980·The British Journal of Ophthalmology·A A Zaidi
Mar 18, 1999·Journal of Cataract and Refractive Surgery·R StegmannD Miller
Oct 12, 2000·Eye·A Mermoud
Dec 29, 2000·Journal of Glaucoma·E J Poulsen, R R Allingham
Mar 19, 2003·The British Journal of Ophthalmology·T ShaarawyA Mermoud
Dec 25, 2003·The British Journal of Ophthalmology·T ShaarawyA Mermoud
Mar 10, 2004·European Journal of Ophthalmology·Y LachkarP Demailly
Jun 5, 2004·Journal of Cataract and Refractive Surgery·Tarek ShaarawyAndré Mermoud
Nov 7, 2007·Eating and Weight Disorders : EWD·R M Page, J Suwanteerangkul
Feb 28, 2008·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Salvatore CillinoGaetano Lodato
Feb 28, 2008·Journal of Glaucoma·Fernando Galassi, Barbara Giambene
Jan 20, 2009·Experimental Eye Research·Albert Alm, Siv F E Nilsson
Jan 27, 2009·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Jin-Wei ChengYou Li

❮ Previous
Next ❯

Citations

Jun 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jin-Wei ChengRui-Li Wei
Jul 3, 2010·Clinical Ophthalmology·George KitsosKonstantinos Psilas
Jun 3, 2014·Indian Journal of Ophthalmology·Brian J Song, Joseph Caprioli
Jan 31, 2015·International Ophthalmology·Jordi LoscosJulio de la Cámara
Feb 18, 2014·The Cochrane Database of Systematic Reviews·Mohamed A EldalyRichard Wormald
Sep 6, 2019·Journal of Ophthalmology·Kentaro IwasakiMasaru Inatani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.